23andMe receives new FDA green light

23andMe (ME) rises on FDA clearance to report more genetic variants. (00:26) UPS offers some pilots an early retirement package. (01:12) Bernstein says reclassifying cannabis as Schedule III not preferred outcome. (01:47)

Episode transcripts seekingalpha.com/wsb.
Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.

Show links:

Fresh stimulus from China to bolster crisis-hit property sector
Aditxt stock drops 48% on $10M private placement
Li Auto sales rose 663.8% Y/Y in August
Ford Motor offers UAW workers a 15% combined wage raise